Rocket Pharmaceuticals, Inc.
RCKT
$3.47
$0.133.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 2.16% | 16.16% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.28% | 10.17% | |||
| Operating Income | 3.28% | -10.17% | |||
| Income Before Tax | 377.00% | -11.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 358.89% | -11.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 358.89% | -11.89% | |||
| EBIT | 3.28% | -10.17% | |||
| EBITDA | 3.33% | -10.88% | |||
| EPS Basic | 357.28% | -11.54% | |||
| Normalized Basic EPS | 4.23% | -11.06% | |||
| EPS Diluted | 354.48% | -11.54% | |||
| Normalized Diluted EPS | 5.62% | -11.06% | |||
| Average Basic Shares Outstanding | 0.63% | 0.31% | |||
| Average Diluted Shares Outstanding | 2.12% | 0.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||